Olympus UK SUP3R-19
SUPER-19 is the newest addition to the powerful lineup of Andro prohormones by Olympus UK. SUP3R-19 contains 60 capsules with 110 mg (6,600 mg per bottle) of 19-Nor Andro as well as absorption enhancement in the form of our proprietary S-SEDDs delivery system. Olympus Labs takes great pride in unleashing this powerful compound. We now have yet another weapon for the arsenal of all those striving to abandon mediocrity and ascend to Demi-God status.
19-Nor Andro is an excellent compound regardless of your goals; it can aid in gaining lean body mass and strength, or help maintain muscle and strength when dieting with a caloric deficit. SUP3R-19 stacks well with almost any compound. 19 Nor Andro, also known as 19-Nor-DHEA, 19 NorAndrosterone or, 19 Nor Dehydroepiandrosterone is a naturally occurring metabolite of DHEA in the human body.
Similar to other DHEA metabolites, such as 1-Andro and 4-Andro, 19 Nor Andro converts via a two step enzyme pathway into it’s main metabolite. Once the enzymatic process is finished, the end-product is powerful hormone that is even more anabolic than testosterone yet less androgenic. This simply means powerful growth potential and a very low risk of unwanted side effects like hair loss, gyno, or acne. 19 Nor Andro is a great component of any cycle that has the goal of increasing strength and mass. It does not directly convert into estrogen, which allows for relatively dry gains depending on how it is used. 19 Nor Andro, due to being non-methylated is also relatively mild on the liver and other organs and health markers. This also makes it an ideal compound to stack with other various compounds. The strength of SUP3R-19 is also enhanced by the addition of our proven S-SEDDs delivery system for increased bioavailability.
SEDDS have been proven in the last two decades to be a phenomenal success. They are able to overcome some of the biggest challenges confronting contemporary delivery science today by improving on the oral bioavailability of compounds with poor and inconsistent gastrointestinal absorption. SEDDS do so by facilitating absorption of compounds via the intestinal lymphatic system and thus circumnavigating the hepatic first-pass effect. The lymphatic system is a drainage network that extends throughout the entire body in proximity to the circulatory system and is a logical target since orally administered compounds can work more effectively when transported selectively to the intestinal lymphatic system. The bioavailability of compounds that undergo significant first-pass metabolism in the liver, as Andros do without enhanced delivery methods, can be improved dramatically by utilizing the lymphatic system for absorption in the intestine, thus avoiding the destructive first-pass effect in the liver.
However SEDDS are typically prepared in a liquid form, which can result in some disadvantages, for example, low stability, large volume of dose and issues with handling and portability. To overcome these issues, solid-SEDDS (S-SEDDS) has emerged to improve upon an already excellent delivery system. Through solidification of liquid self-emulsifying systems into powders the liquid SEDDS can be converted into solid dosage form without affecting compound release property. Thus, S-SEDDS combines the advantages of SEDDS (i.e., enhanced solubility and bioavailability) with those of solid dosage forms (e.g., high stability and reproducibility, compact dosage form and ease of handling and portability). Though it has little, if any, current presence in the world of supplementation, S-SEDDS is a cutting edge and highly effective delivery system utilized by the pharmaceutical industry. It is without a doubt one of the most effective means by which to deliver any compound at this point in time, and stands to replace other more antiquated methods delivery in the very near future.